Nuveen Asset Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $868K | Hold |
112,316
| – | – | ﹤0.01% | 2768 |
|
|
2024
Q3 | $1.18M | Hold |
112,316
| – | – | ﹤0.01% | 2682 |
|
|
2024
Q2 | $1.31M | Buy |
112,316
+6,548
| +6% | +$76.6K | ﹤0.01% | 2590 |
|
|
2024
Q1 | $2.23M | Hold |
105,768
| – | – | ﹤0.01% | 2351 |
|
|
2023
Q4 | $1.9M | Buy |
105,768
+3,591
| +4% | +$64.5K | ﹤0.01% | 2434 |
|
|
2023
Q3 | $1.68M | Sell |
102,177
-1,364
| -1% | -$22.5K | ﹤0.01% | 2372 |
|
|
2023
Q2 | $2.07M | Hold |
103,541
| – | – | ﹤0.01% | 2324 |
|
|
2023
Q1 | $1.96M | Sell |
103,541
-14,186
| -12% | -$268K | ﹤0.01% | 2339 |
|
|
2022
Q4 | $2.67M | Sell |
117,727
-17,640
| -13% | -$400K | ﹤0.01% | 2251 |
|
|
2022
Q3 | $3.58M | Sell |
135,367
-3,988
| -3% | -$105K | ﹤0.01% | 2089 |
|
|
2022
Q2 | $3.44M | Buy |
139,355
+12,889
| +10% | +$318K | ﹤0.01% | 2164 |
|
|
2022
Q1 | $3.68M | Sell |
126,466
-417
| -0.3% | -$12.1K | ﹤0.01% | 2224 |
|
|
2021
Q4 | $3.97M | Sell |
126,883
-10,616
| -8% | -$332K | ﹤0.01% | 2247 |
|
|
2021
Q3 | $6.19M | Sell |
137,499
-11,840
| -8% | -$533K | ﹤0.01% | 2095 |
|
|
2021
Q2 | $5.8M | Sell |
149,339
-16,128
| -10% | -$627K | ﹤0.01% | 2175 |
|
|
2021
Q1 | $5.64M | Buy |
165,467
+36,370
| +28% | +$1.24M | ﹤0.01% | 2115 |
|
|
2020
Q4 | $5.86M | Sell |
129,097
-2,502
| -2% | -$113K | ﹤0.01% | 1989 |
|
|
2020
Q3 | $3.62M | Sell |
131,599
-12,426
| -9% | -$342K | ﹤0.01% | 2093 |
|
|
2020
Q2 | $5.3M | Buy |
144,025
+4,390
| +3% | +$162K | ﹤0.01% | 1862 |
|
|
2020
Q1 | $4.52M | Buy |
139,635
+1,445
| +1% | +$46.8K | ﹤0.01% | 1766 |
|
|
2019
Q4 | $5.66M | Sell |
138,190
-42,929
| -24% | -$1.76M | ﹤0.01% | 1918 |
|
|
2019
Q3 | $6.45M | Sell |
181,119
-17,557
| -9% | -$625K | ﹤0.01% | 1819 |
|
|
2019
Q2 | $10.2M | Buy |
+198,676
| New | +$10.2M | ﹤0.01% | 1600 |
|